Department of Medicine (Austin), University of Melbourne, Melbourne, Victoria, Australia.
Department of Medicine (Austin), University of Melbourne, Melbourne, Victoria, Australia; Dept of Endocrinology, Austin Health, Melbourne, Victoria, Australia.
Appetite. 2020 Aug 1;151:104708. doi: 10.1016/j.appet.2020.104708. Epub 2020 Apr 10.
The prevalence of emotional eating (EE) has increased in the general population over past decades. There is limited information on how common EE is among people seeking obesity treatment. We aimed to estimate the proportion of people with EE, and strength of associations between a predefined set of factors and EE in people referred for obesity treatment.
Cross-sectional study recruiting 387 adults from a hospital obesity service. "Emotional eating" was defined as Emotional Eating Scale (EES) score ≥25. Strength of associations were estimated by boot-strapped quantile regression analysis. Results are presented as quantile difference (QD) of EES scores at the 25th, 50th or 75th quantile, and 95% confidence intervals (95%CI).
The study population consisted of 71% women, with a median age of 52 years (interquartile range [IQR]: 42, 61), and a median body mass index of 42 kg/m (IQR: 37, 49). 187 participants were managed with lifestyle modification alone, 103 with the addition of obesity pharmacotherapy, 79 with bariatric surgery, and 18 with both bariatric surgery and medications. EE was reported by an estimated 58% (95%CI: 53, 63) of participants. Factors with the largest and most consistent magnitude of association with EES differences include age, sex, use of glucagon-like peptide-1 (GLP-1) agonists, history of sleeve gastrectomy and recent bariatric surgery.
Emotional eating affected more than half of people referred for obesity treatment. Age, sex, use of GLP-1 agonists, history of sleeve gastrectomy and recent bariatric surgery had the strongest associations with EE. These findings allow hypothesis generation about the underlying physiological mechanisms behind emotional eating for investigation in future research.
在过去几十年中，普通人群中情绪性进食（EE）的患病率有所增加。关于接受肥胖治疗的人群中 EE 有多普遍，我们知之甚少。本研究旨在评估 EE 的比例，并估计肥胖治疗人群中一组既定因素与 EE 之间的关联强度。
横断面研究，从医院肥胖门诊招募 387 名成年人。“情绪性进食”定义为情绪进食量表（EES）得分≥25 分。关联强度通过bootstrap 分位数回归分析进行估计。结果表示为 EES 得分在第 25、50 或 75 分位数的分位数差异（QD）和 95%置信区间（95%CI）。
研究人群中 71%为女性，平均年龄为 52 岁（四分位间距 [IQR]：42，61），平均体重指数为 42kg/m（IQR：37，49）。187 名参与者接受单纯生活方式干预，103 名参与者接受肥胖药物治疗联合生活方式干预，79 名参与者接受减肥手术治疗，18 名参与者同时接受减肥手术和药物治疗。据估计，58%（95%CI：53，63）的参与者报告存在 EE。与 EES 差异相关性最强且最一致的因素包括年龄、性别、胰高血糖素样肽-1（GLP-1）激动剂的使用、胃袖状切除术史和近期减肥手术。
情绪性进食影响了超过一半接受肥胖治疗的人群。年龄、性别、GLP-1 激动剂的使用、胃袖状切除术史和近期减肥手术与 EE 关联最强。这些发现为进一步研究情绪性进食背后的潜在生理机制提供了假设。
